Xilio Therapeutics, Inc.
XLO
Revenue
19.07M
▲10.98M▲135.85%
3 Months ChangeAssets
133.69M
▼-119.00k▼-0.08893%
3 Months ChangeLiabilities
141.79M
▲15.05M▲11.87%
3 Months ChangeFree Cash Flow
28.96M
▲54.38M▲213.91%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001193125-26-097603
2026-02-24
Form 8-K
ID: 0001193125-26-065234
2026-02-12
Form 8-K
ID: 0001193125-26-048942
2026-01-08
Form 8-K
ID: 0001193125-26-007063
2026-01-05
Form 8-K
ID: 0001193125-26-001580
2025-11-25
Form 8-K
ID: 0001193125-25-297165
2025-11-13
Form 10-Q
ID: 0001193125-25-278837
2025-11-13
Form 8-K
ID: 0001193125-25-278835
2025-11-07
Form 8-K
ID: 0001193125-25-271189
2025-10-03
Form 8-K
ID: 0001193125-25-229231